EUVIMEDEUVIMED entdecken
Crossref

Cholecystohepatic shunt pathway reduces secondary bile acid accumulation to enhance natural killer T cell‐mediated anti‐hepatocellular carcinoma immunity

Shenglu Liu iD, Haoxian Gou, Hui Wei, Shengdeng Chen, Shijie Zhuo, Ming Luo, Shu Qin, Mengyu Zhang, Jiatong Chen, Zhiwei Huang, Xianming Xia, Xiaoli Yang und 1 weitere

Journal of Gastroenterology and Hepatology · 2024

DOI: 10.1111/jgh.16548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Shenglu Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery (Hepatopancreatobiliary Surgery), The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Natural Killer T-Cells, Liver Neoplasms, Bile Acids and Salts. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Luzhou Administration of Science and Technology, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim The impact of cholecystectomy, which blocks the cholecystohepatic shunt pathway (CHSP), on the prognosis of patients with hepatocellular carcinoma (HCC) is unclear. Hepatic secondary bile acids (BAs) inhibit natural killer T (NKT) cell‐mediated immunity against HCC, and the regulation of homeostasis of hepatic secondary BAs is controlled by the CHSP. However, the influence of CHSP on NKT cell‐mediated immunity against HCC remains unclear.

Methods

The clinical data of hospitalized patients undergoing HCC resection were collected. Meanwhile, an in situ HCC mouse model was established, and the CHSP was augmented using oleanolic acid (OA).

Results

After 1:1 propensity score matching, Cox regression analysis revealed that cholecystectomy was an independent risk factor for HCC recurrence after hepatectomy ( P = 0.027, hazard ratio: 1.599, 95% confidence interval: 1.055–2.422). Experimentally, when OA enhanced CHSP, a significant decrease was observed in the accumulation of secondary BAs in the livers of mice. Additionally, a significant increase was observed in the levels of C‐X‐C ligand 16 and interferon γ in the serum and tumor tissues. Further, the percentage of C‐X‐C receptor 6 (+) NKT cells in the tumor tissues increased significantly, and the growth of liver tumors was inhibited.

Conclusions

This clinical study revealed that cholecystectomy promoted the recurrence after radical hepatectomy in patients with HCC. Preserving the normal‐functioning gallbladder as much as possible during surgery may be beneficial to the patient's prognosis. Further investigation into the mechanism revealed that CHSP enhanced NKT cell‐mediated immunity against HCC by reducing the hepatic accumulation of secondary BAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularNatural Killer T-CellsLiver NeoplasmsBile Acids and SaltsAnimalsMaleHumansFemaleCholecystectomyDisease Models, AnimalMiceHepatectomyMiddle AgedOleanolic AcidLiverMice, Inbred C57BLImmunity, CellularNeoplasm Recurrence, LocalInterferon-gammaRisk FactorsAged

Stichwörter der Autor:innen

NKT cellcholecystectomycholecystohepatic shunt pathwaysecondary bile acids

Substanzen

Bile Acids and SaltsOleanolic AcidInterferon-gamma

Autor:innen und Institutionen

  • Department of General Surgery (Hepatopancreatobiliary Surgery), The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
  • Academician (Expert) Workstation of Sichuan Province, Metabolic Hepatobiliary and Pancreatic Diseases Key Laboratory of Luzhou City, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
  • Department of Hepatopancreatobiliary Surgery, Zizhong County People's Hospital, Neijiang, Sichuan, China.

ORCID-Profile: Shenglu Liu

Förderung

  • Luzhou Administration of Science and Technology
  • National Natural Science Foundation of China

Zitieren

APA

Liu, S., Gou, H., Wei, H., Chen, S., Zhuo, S., Luo, M., Qin, S., Zhang, M., Chen, J., Huang, Z., Xia, X., Yang, X., & He, K. (2024). Cholecystohepatic shunt pathway reduces secondary bile acid accumulation to enhance natural killer T cell‐mediated anti‐hepatocellular carcinoma immunity. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16548

Vancouver

Liu S, Gou H, Wei H, Chen S, Zhuo S, Luo M, et al. Cholecystohepatic shunt pathway reduces secondary bile acid accumulation to enhance natural killer T cell‐mediated anti‐hepatocellular carcinoma immunity. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16548

BibTeX
@article{Liu2024,
  author = {Liu, Shenglu and Gou, Haoxian and Wei, Hui and Chen, Shengdeng and Zhuo, Shijie and Luo, Ming and Qin, Shu and Zhang, Mengyu and Chen, Jiatong and Huang, Zhiwei and Xia, Xianming and Yang, Xiaoli and He, Kai},
  title = {Cholecystohepatic shunt pathway reduces secondary bile acid accumulation to enhance natural killer T cell‐mediated anti‐hepatocellular carcinoma immunity},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1111/jgh.16548}
}
Kostenlos starten →